3.73

1.36% 0.05

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $3.73, with a volume of 871.85K. It is up +1.36% in the last 24 hours and up +29.97% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Previous Close:

$3.68

Open:

$3.7

24h Volume:

871.85K

Relative Volume:

0.55

Market Cap:

$550.16M

Revenue:

$185.74M

Net Income/Loss:

$-230.76M

P/E Ratio:

-4.1175

EPS:

-0.9059

Net Cash Flow:

$-70.72M

1W Performance:

+5.07%

1M Performance:

+29.97%

6M Performance:

+18.79%

1Y Performance:

+83.74%

1-Day Range:

$3.66

$3.765

1-Week Range:

$3.47

$3.765

52-Week Range:

$1.95

$4.105

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1112)

Industry

Biotechnology (622)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

435

Twitter

Next Earnings Date

2026-05-07

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	3.73	550.16M	185.74M	-230.76M	-70.72M	-0.9059
VRTX Vertex Pharmaceuticals Inc	423.92	107.83B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	701.42	73.54B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	783.50	48.72B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	296.11	39.51B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	293.86	32.66B	5.36B	287.73M	924.18M	2.5229

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

May 01, 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

May 01, 2026

Apr 30, 2026

Maravai LifeSciences (MRVI) Expected to Announce Earnings on Thursday - MarketBeat

Apr 30, 2026

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat

Apr 30, 2026

Apr 27, 2026

What management guidance Maravai (MRVI)? (-0.14%) 2026-04-27Risk Analysis - Newser

Apr 27, 2026

Apr 24, 2026

[ARS] MARAVAI LIFESCIENCES HOLDINGS, INC. SEC Filing - Stock Titan

Apr 24, 2026

Maravai (MRVI) sets 2026 virtual meeting, board elections and say-on-pay - Stock Titan

Apr 24, 2026

Apr 20, 2026

Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - The National Law Review

Apr 20, 2026

Press Release: Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 - Moomoo

Apr 20, 2026

Apr 17, 2026

Maravai LifeSciences Holdings (MRVI) Stock Analysis: A Closer Look at a 34.90% Potential Upside - DirectorsTalk Interviews

Apr 17, 2026

Apr 16, 2026

Investors Purchase Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - MarketBeat

Apr 16, 2026

Apr 14, 2026

Maravai LifeSciences (NASDAQ:MRVI) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Apr 14, 2026

Maravai LifeSciences (MRVI) Carrying Moderately Bullish Sentiment Despite Options-Linked Volatility - Insider Monkey

Apr 14, 2026

Apr 13, 2026

8 Best Life Sciences Penny Stocks to Buy - Insider Monkey

Apr 13, 2026

VIX Spike: Will Maravai LifeSciences Holdings Inc stock hit new highs in YEAR2026 Key Highlights & Smart Investment Allocation Insights - baoquankhu1.vn

Apr 13, 2026

How Maravai LifeSciences (MRVI) Q4 Results Are Shaping A Cautious Valuation Narrative - Yahoo Finance

Apr 13, 2026

Is Maravai (MRVI) Stock Stronger Than Peers | Price at $3.06, Down 0.33%Support Bounce - Newser

Apr 13, 2026

Apr 12, 2026

Chart Watch: Will Maravai LifeSciences Holdings Inc stock hit new highs in YEAR2026 Market WrapUp & AI Based Trade Execution Alerts - baoquankhu1.vn

Apr 12, 2026

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Is Maravai (MRVI) Stock Priced Correctly | Price at $3.17, Up 9.86%Expert Momentum Signals - Xã Vĩnh Công

Apr 08, 2026

Apr 07, 2026

Gainers Report: How does Maravai LifeSciences Holdings Inc score in quality rankingsProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026